BioSpace News Archive

A study conducted by the research team at Valisure, America’s first online Analytical Pharmacy, revealed strong evidence that, on average, rapid- or fast-release acetaminophen gelcaps dissolve slower than standard release tablets from the same companies.

The Urology Care Foundation, the world’s leading nonprofit urological health foundation and the official foundation of the American Urological Association (AUA), is pleased to announce the selection of Joel Berends as the inaugural recipient of its new Physician Scientist Residency Training Award.

ReWalk Robotics, Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) applauds United Spinal Association’s recommendation, dated November 9, 2018, that health insurance providers consider the use of powered exoskeleton devices as medically necessary for eligible individuals with spinal cord injuries

GeneNews Limited (TSX:GEN) (“GeneNews” or the “Company”) today announced operational and financial results for the three-month and nine-month periods ended September 30, 2018 and provided a progress update on its business.

Syros Pharmaceuticals (NASDAQ: SYRS), a leader in the development of medicines that control the expression of genes, today announced that data from the dose escalation portion of its Phase 1 trial of SY-1365, its first-in-class selective cyclin-dependent kinase 7 (CDK7) inhibitor, demonstrated proof-of-mechanism at tolerable doses in patients with advanced solid tumors.

Robust system designed to optimize imaging business for both outpatient and inpatient facilities

Company debuts SonoSite Synchronicity, a new robust workflow solution

Company unveils two dedicated solutions designed to address imaging needs in the operating room (OR)

New Inhale for Life PSA videos feature six lung cancer survivors living well with their disease because of biomarker-driven therapeutics

This new designation for the company certifies a high level of quality assurance and consistency.